1 Answers
Indacaterol is indicated for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Indacaterol is a long-acting β2-adrenergic agonist indicated for long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Onriva Bexicap Inhalation Capsule সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Onriva
3873 views
Answered